The store will not work correctly when cookies are disabled.
5-((2-(6-Methoxy-2-methylquinolin-4-yl)hydrazono)methyl)benzene-1,3-diol
ID: ALA4558270
PubChem CID: 155557679
Max Phase: Preclinical
Molecular Formula: C18H17N3O3
Molecular Weight: 323.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2nc(C)cc(N/N=C/c3cc(O)cc(O)c3)c2c1
Standard InChI: InChI=1S/C18H17N3O3/c1-11-5-18(16-9-15(24-2)3-4-17(16)20-11)21-19-10-12-6-13(22)8-14(23)7-12/h3-10,22-23H,1-2H3,(H,20,21)/b19-10+
Standard InChI Key: XBVNYCYQLJIXQY-VXLYETTFSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
35.5464 -13.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5453 -14.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2533 -14.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2515 -12.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9601 -13.3149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9609 -14.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6694 -14.5410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3777 -14.1302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3730 -13.3081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6638 -12.9047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0870 -14.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6595 -12.0875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3650 -11.6752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8386 -12.9101 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8384 -12.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0749 -12.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7804 -11.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4888 -12.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1938 -11.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1899 -10.8476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4751 -10.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7730 -10.8570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9035 -12.0709 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.4679 -9.6258 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
10 12 1 0
12 13 1 0
1 14 1 0
14 15 1 0
13 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
19 23 1 0
21 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.35 | Molecular Weight (Monoisotopic): 323.1270 | AlogP: 3.41 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.97 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: 7.41 | CX LogP: 3.18 | CX LogD: 3.01 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -0.88 |
References
1. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S.. (2019) Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2)., 182 [PMID:31514018] [10.1016/j.ejmech.2019.111649] |